With respect to South Korea, Novartis settled sure nicely-publicized allegations that it experienced made inappropriate payments to HCPs in South Korea via round tables and third-occasion health care journals. Novartis Korea allegedly transmitted poor honoraria to HCPs for round tables through medical journals to stop compliance scrutiny, and endur